Indication

Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor

Diarrhea associated with a vasoactive intestinal peptide (VIP)-secreting tumor is a severe, profuse secretory diarrhea caused by autonomous, unregulated humoral secretion from a neuroendocrine neoplasm (VIPoma), which most commonly arises from the non-beta islet cells of the pancreas or occasionally from neural crest tissues. Read more about Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor

23 drugs 20 manufacturers

Advertisement

Drugs that treat it

Common Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor therapies.

Showing 19–23 of 23 drugs

Filter & compare in the drug finder →Opens the drug finder with Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor.

Diarrhea associated with a vasoactive intestinal peptide (VIP)-secreting tumor is a severe, profuse secretory diarrhea caused by autonomous, unregulated humoral secretion from a neuroendocrine neoplasm (VIPoma), which most commonly arises from the non-beta islet cells of the pancreas or occasionally from neural crest tissues.

Excessive circulating VIP binds to intestinal epithelial receptors, activating adenylate cyclase to stimulate massive mucosal secretion of water and electrolytes while inhibiting gastric acid output and intestinal absorption.

This condition manifests in affected patients as copious, tea-colored watery stools—persisting despite fasting—and classically leads to profound hypokalemia, hypochlorhydria or achlorhydria, dehydration, and normal anion-gap metabolic acidosis as part of Verner-Morrison (WDHA) syndrome.

Personalize your experience

Follow Diarrhea associated with vasoactive intestinal peptide (VIP)-secreting tumor and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it